Literature DB >> 12203026

Fractionation of vanadium complexes in serum, packed cells and tissues of Wistar rats by means of gel filtration and anion-exchange chromatography.

Koen De Cremer1, Marijn Van Hulle, Cyrille Chéry, Rita Cornelis, Karel Strijckmans, Richard Dams, Norbert Lameire, Raymond Vanholder.   

Abstract

Male Wistar rats were intraperitoneally injected with [(48)V]vanadium tracer to (1) investigate the distribution of vanadium over different tissues and (2) study the distribution of vanadium over the proteins and peptides in serum, packed cells and homogenates of tissues by means of liquid chromatography experiments (size exclusion, ion exchange). Target organs were primarily kidney, bone, spleen and liver. In serum we found that vanadium was mainly bound to transferrin; however, a small amount was also bound to albumin. Besides these two complexes, a significant part of vanadium occurred as readily exchangeable ("free") vanadium. In packed cells, vanadium is mainly bound to hemoglobin and to two abundant low molecular mass complexes. The chromatograms of tissues (kidney, liver, testes, spleen and lung) show similar high molecular mass complexes (vanadium co-elutes with ferritin, transferrin and hemoglobin). Between the low molecular mass complexes there are similar peaks for spleen, testes and kidneys on the one hand, and liver and lung on the other hand, albeit the differences are small. In the case of lung, there is an additional low molecular mass peak.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12203026     DOI: 10.1007/s00775-002-0376-9

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  8 in total

1.  X-ray-induced photo-chemistry and X-ray absorption spectroscopy of biological samples.

Authors:  Graham N George; Ingrid J Pickering; M Jake Pushie; Kurt Nienaber; Mark J Hackett; Isabella Ascone; Britt Hedman; Keith O Hodgson; Jade B Aitken; Aviva Levina; Christopher Glover; Peter A Lay
Journal:  J Synchrotron Radiat       Date:  2012-10-18       Impact factor: 2.616

2.  CN-GELFrEE - Clear Native Gel-eluted Liquid Fraction Entrapment Electrophoresis.

Authors:  Rafael D Melani; Henrique S Seckler; Owen S Skinner; Luis H F Do Vale; Adam D Catherman; Pierre C Havugimana; Marcelo Valle de Sousa; Gilberto B Domont; Neil L Kelleher; Philip D Compton
Journal:  J Vis Exp       Date:  2016-02-29       Impact factor: 1.355

3.  Binding of V(IV)O²⁺ to the Fe binding sites of human serum transferrin. A theoretical study.

Authors:  Gonçalo C Justino; Eugenio Garribba; João Costa Pessoa
Journal:  J Biol Inorg Chem       Date:  2013-10       Impact factor: 3.358

4.  Expressed sequence tag analysis of vanadocytes in a vanadium-rich ascidian, Ascidia sydneiensis samea.

Authors:  Nobuo Yamaguchi; Kei Kamino; Tatsuya Ueki; Hitoshi Michibata
Journal:  Mar Biotechnol (NY)       Date:  2003-11-06       Impact factor: 3.619

5.  The renal effects of vanadate exposure: potential biomarkers and oxidative stress as a mechanism of functional renal disorders--preliminary studies.

Authors:  Agnieszka Ucibior; Dorota Gołębiowska; Agnieszka Adamczyk; Irmina Niedźwiecka; Emilia Fornal
Journal:  Biomed Res Int       Date:  2014-01-28       Impact factor: 3.411

Review 6.  Vanadium: Risks and possible benefits in the light of a comprehensive overview of its pharmacotoxicological mechanisms and multi-applications with a summary of further research trends.

Authors:  Agnieszka Ścibior; Łukasz Pietrzyk; Zbigniew Plewa; Andrzej Skiba
Journal:  J Trace Elem Med Biol       Date:  2020-04-12       Impact factor: 3.849

Review 7.  Vanadium in Biological Action: Chemical, Pharmacological Aspects, and Metabolic Implications in Diabetes Mellitus.

Authors:  Samuel Treviño; Alfonso Díaz; Eduardo Sánchez-Lara; Brenda L Sanchez-Gaytan; Jose Manuel Perez-Aguilar; Enrique González-Vergara
Journal:  Biol Trace Elem Res       Date:  2018-10-22       Impact factor: 3.738

8.  Changes in iron metabolism and oxidative status in STZ-induced diabetic rats treated with bis(maltolato) oxovanadium (IV) as an antidiabetic agent.

Authors:  Cristina Sánchez-González; Carlos López-Chaves; Cristina E Trenzado; Pilar Aranda; María López-Jurado; Jorge Gómez-Aracena; María Montes-Bayón; Alfredo Sanz-Medel; Juan Llopis
Journal:  ScientificWorldJournal       Date:  2014-01-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.